Astal Laboratories manufactures high-quality active pharmaceutical ingredients that pharma companies across the world depend on — built on rigorous R&D, uncompromising quality systems, and sustainable manufacturing.
Founded in 1993 (formerly Macro International Limited), Astal Laboratories Limited has rapidly established itself as a beacon of innovation and reliability in the pharmaceutical bulk drug industry.
Our venture into active pharmaceutical ingredients marks a significant milestone in redefining industry standards. With a strong emphasis on quality, efficiency, and sustainability, we are committed to meeting the growing global demand for essential pharmaceutical ingredients.
More About Astal
Innovation is the essential prerequisite at our R&D — from process chemistry to scale-up.
Quality and compliance are the prime philosophies guiding every batch we manufacture.
Purpose-built facilities engineered for consistent, high-volume API production.
Eco-friendly processes and responsible resource use across our operations.
A broad and growing portfolio of active pharmaceutical ingredients serving multiple therapeutic segments.
High-purity intermediates and APIs for the anti-infective segment.
Precision-manufactured ingredients supporting cardiovascular therapies.
Rigorously tested ingredients for central nervous system formulations.
As a listed entity, Astal Laboratories is committed to timely disclosures, strong corporate governance, and consistent value creation for our shareholders.
Access our yearly performance and strategy reports.
Quarterly and annual financial statements.
Policies, board composition and compliance disclosures.
Stock-exchange filings and press releases.
Talk to our team about sourcing, capacity and regulatory documentation.
